TriSalus Life Sciences Inc. (TLSI) Stock Forecast & Price Target
TriSalus Life Sciences Inc. · NASDAQ
$4.73-0.27 (-5.40%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering TriSalus Life Sciences Inc, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $7.00 to $8.00, so the covering firms are broadly aligned. The average target of $7.50 sits 59% above the current $4.73. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.07 next quarter toward $-0.26 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Strong Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to TriSalus Life Sciences Inc.
As of Sep, 2 of 2 firms rate TLSI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
TLSI EPS & revenue forecast
EPS · NEXT QUARTER
$-0.07
Range $-0.11 – $-0.05 · 4 analysts · -68% YoY
Next period, 4 analysts expect TriSalus Life Sciences Inc. to earn $-0.07 a share (range $-0.11 – $-0.05), versus $-0.21 a year earlier. Full-year consensus is $-0.33, growing to $-0.26 the year after.
REVENUE · NEXT QUARTER
$18.2M
Range $15.8M – $19.6M · 4 analysts · +38% YoY
Revenue is expected to reach $18.2M (range $15.8M – $19.6M), +37.7% year-over-year. Full-year consensus is $52.5M, rising to $73.5M next year.
Top analysts covering TriSalus Life Sciences Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TLSI.
#1
Ross Osborn
Cantor Fitzgerald · Rank #166
Buy
$9.00+90.3% to target
Overall win rate
33%
+ Follow
#2
William Plovanic
Canaccord Genuity · Rank #243
Buy
$7.00+48.0% to target
Overall win rate
37%
+ Follow
#3
JW
Jason Wittes
Roth MKM · Rank #311
Buy
$11.00+132.6% to target
Overall win rate
39%
+ Follow
#4
Frank Takkinen
Lake Street · Rank #394
Buy
$8.00+69.1% to target
Overall win rate
26%
+ Follow
#5
Carl Byrnes
Northland Capital Markets
Buy
$8.00+69.1% to target
Coverage
—
+ Follow
TLSI stock forecast FAQ
What is TLSI's average 12-month price target?+
The 2 analysts with a live target average $7.50 for TriSalus Life Sciences Inc. over the next 12 months, ranging from a $8.00 high to a $7.00 low.
Is TLSI stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for TLSI?+
The Street-high target is $8.00 (Lake Street), and the Street-low is $7.00 (Canaccord Genuity). The average of all 2 active targets is $7.50.
How many Wall Street analysts cover TLSI?+
2 analysts have an active rating on TriSalus Life Sciences Inc., and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering TLSI?+
Among analysts who currently cover TLSI, Ross Osborn of Cantor Fitzgerald has the strongest overall Quantellect track record (Rank #166). Their current call is Buy with a $9.00 target.
What is TriSalus Life Sciences Inc.'s projected EPS for next quarter?+
The consensus estimate is $-0.07 per share (range $-0.11 – $-0.05) across 4 analysts. Full-year EPS is projected at $-0.33, rising to $-0.26 the following year.
How much revenue is TriSalus Life Sciences Inc. expected to report next quarter?+
Consensus revenue is $18.2M (range $15.8M – $19.6M). Full-year revenue is projected at $52.5M, growing to $73.5M next year.
Have analysts been upgrading or downgrading TLSI lately?+
As of Sep, 2 of 2 firms rate TLSI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TLSI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
